This article outlines recent taxonomic and nomenclature changes in the Streptococcus genus over the past 15 years, driven by molecular techniques like DNA-DNA reassociation and 16S rDNA sequencing. The Streptococcus genus has expanded from seven to 17 genera of gram-positive cocci. The article discusses beta-hemolytic and non-beta-hemolytic streptococci, including species like Streptococcus pyogenes (group A strep), Streptococcus agalactiae (group B strep), and Streptococcus dysgalactiae subsp. equisimilis. It also covers non-beta-hemolytic species such as Streptococcus pneumoniae, Streptococcus bovis, and Streptococcus suis. The article highlights the importance of phenotypic and genetic testing for accurate identification, noting that many new species have been added, and some genera like Abiotrophia, Granulicatella, and Facklamia have been split from Streptococcus. The article also discusses the challenges of identifying streptococci due to limited phenotypic markers and the need for molecular methods. It emphasizes the importance of accurate identification for clinical management and highlights the role of molecular techniques in redefining species and subspecies. The article concludes with the need for further research to confirm these changes and their clinical significance.This article outlines recent taxonomic and nomenclature changes in the Streptococcus genus over the past 15 years, driven by molecular techniques like DNA-DNA reassociation and 16S rDNA sequencing. The Streptococcus genus has expanded from seven to 17 genera of gram-positive cocci. The article discusses beta-hemolytic and non-beta-hemolytic streptococci, including species like Streptococcus pyogenes (group A strep), Streptococcus agalactiae (group B strep), and Streptococcus dysgalactiae subsp. equisimilis. It also covers non-beta-hemolytic species such as Streptococcus pneumoniae, Streptococcus bovis, and Streptococcus suis. The article highlights the importance of phenotypic and genetic testing for accurate identification, noting that many new species have been added, and some genera like Abiotrophia, Granulicatella, and Facklamia have been split from Streptococcus. The article also discusses the challenges of identifying streptococci due to limited phenotypic markers and the need for molecular methods. It emphasizes the importance of accurate identification for clinical management and highlights the role of molecular techniques in redefining species and subspecies. The article concludes with the need for further research to confirm these changes and their clinical significance.